Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
NCI Corner – Interview with Jeff Abrams
lungcanc
Suicide and Lung Cancer: Screening Is Only the First Step
lungcanc
Profile of Advocacy: Shanghai Cancer Recovery Club
lungcanc
In Speech to Agency, New FDA Commissioner Highlights Anti-Smoking Efforts
lungcanc
Ravi Salgia, MD, PhD
lungcanc
Mental Health Really Matters: Lung Cancer Diagnosis Has the Greatest Risk...
lungcanc
Solange Peters, MD, PhD
lungcanc
Naiyer A. Rizvi, MD
lungcanc
David R. Gandara, MD
lungcanc
Promise of Smoke-Free Future Falls Short
lungcanc
1
...
34
35
36
...
53
Page 35 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS